FALLS CHURCH, Va., Feb. 7 /PRNewswire/ -- The leading provider of news and
information on the U.S. Food and Drug Administration (FDA) today announced the
launch of the only newsletter devoted to tracking and explaining rules,
regulations, pending legislation and other issues affecting Medicare and
Medicaid reimbursement for medical devices.
The new biweekly newsletter, Device Reimbursement Report, gives medical
device makers, hospital administrators, lobbyists and other decisionmakers
advance news and analysis of federal legislation affecting Medicare and
reimbursement issues; up-to-date information on actions, rulings and
timetables coming out of the Centers for Medicare and Medicaid Services (CMS);
and inside looks at lobbying efforts of interested parties.
"Device Reimbursement Report satisfies a major information need among
buyers, users and manufacturers of medical devices," said Cynthia Carter,
publisher of FDAnews. "More than ever before, providers need to know which
devices will get higher reimbursement rates, which ones will be reclassified
with lower rates and how different settings and uses can affect those rates of
reimbursement -- and ultimately their bottom lines."
On Nov. 29, 2001, the CMS released new rules for hospital Outpatient
Prospective Payment Systems (OPPS), shifting to new methods of reimbursement
for more than 1,100 high-tech medical procedures.
"Reimbursement reform is one of the most far-reaching issues affecting
medical devices today," said Richard Crider, editor of Device Reimbursement
Report. "Advance warning of what CMS will reimburse -- and what it will not --
will be the key to profits for both healthcare institutions and manufacturers
in the months and years to come."
Device Reimbursement Report also tracks changes and updates in Ambulatory
Payment Classifications (APCs), as well as APC applications and appeals for
reclassification; and provides its readers with essential details gleaned from
Federal Register notices and CMS memoranda.
Device Reimbursement Report, published 24 times a year, is available in
print and electronic formats for $827/year.
FDAnews is the premier provider of domestic and international regulatory,
legislative and business news and information for executives in industries
regulated by the U.S. Food and Drug Administration and the European
Commission. FDAnews also publishes Devices & Diagnostics Letter, The GMP
Letter, Part 11 Compliance Report and many other information resources to help
medical device and pharmaceutical executives meet their business and
Since 1972, the seasoned staff of FDAnews journalists has been dedicated
to providing executives in the regulated community with timely, insightful and
practical news and analysis on mission critical issues, key industry
developments and regulatory, legislative and policy initiatives.
Pharmaceutical and medical device professionals rely on FDAnews' print and
electronic newsletters, books, special reports, European documents and
conferences to keep abreast of international standards, stay in compliance
with the FDA's complex and ever-changing regulations, get their products to
market faster and boost profits.
MAKE YOUR OPINION COUNT - Click Here